 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1090 | 回復: 3 | |||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
zlwcw管理員
|
[交流]
ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 已有1人參與
|
||
|
ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2011-10-24 20:00 -------------------------------------------------------------------------------- SHANGHAI, October 24, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"  , a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has, through its main Chinese subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner", acquired the assets in Charles River Laboratories International, Inc.'s ("Charles River" Shanghai research facility. As part of the transaction, ShangPharma will take over Charles River's lease for the facility, which will provide the Company with an additional 2,972 square meters (31,990 square feet) of in-vivo research facilities originally designed for GLP Tox studies, and 1,290 square meters (13,885 square feet) of lab and office space. "The acquisition of one of the best designed and constructed state-of-the-art research facilities and laboratories in China is a major step forward for ShangPharma's in-vivo pharmacology services, which we expect to be a significant revenue growth driver going forward, along with biologics; research manufacturing; and integrated discovery and development services," Michael Xin Hui, founder and Chief Executive Officer of ShangPharma, commented. "The added world-class research capacity should enable ShangPharma to become a top global player in the area of comprehensive in-vivo pharmacology services with specialized capabilities." Kevin Chen, ShangPharma's President and Chief Operating Officer, commented, "This transaction nearly triples ShangPharma's overall research model production and research capacity, positioning us to further leverage China's advantages in the area of in-vivo studies. The location of this facility within ShangPharma's main research campus is a notable strategic advantage, helping us to achieve significant operating efficiencies through consolidation with our current facilities." "This acquisition from Charles River should support accelerated growth in ShangPharma's biology, preclinical development and biologics services for the next several years," added William Dai, ShangPharma's Chief Financial Officer. "ShangPharma's strong cash position has enabled us to make this strategic investment, which we expect will provide excellent returns and maximize shareholder value." Financial terms of the deal, which is subject to customary closing conditions, were not announced. ABOUT SHANGPHARMA CORPORATION ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com. For further information, please contact: ShangPharma Ms. Lan Xie VP of Finance and Investor Relations Email: ir@shangpharma.com Brunswick Group Josh Gartner Email: shangpharma@brunswickgroup.com Phone: 86-10-5960-8600 |
回復此樓» 猜你喜歡
105500藥學求調劑，一志愿山東大學藥學，348分
已經(jīng)有3人回復
-
SUES&NERCN課題組接受碩士生調劑 (學碩1名+專碩1名)
已經(jīng)有0人回復
-
藥理學論文潤色/翻譯怎么收費?
已經(jīng)有108人回復
-
考試
已經(jīng)有2人回復
-
【上海調劑急錄】代碼1007/1055/0806/0703./0780./0836等速點�。∩钤熨Y源滿格！
已經(jīng)有9人回復
-
【調劑上岸】985聯(lián)合培養(yǎng)！1007/1055/08..07..等，醫(yī)藥生化環(huán)材計算機，速來！
已經(jīng)有5人回復
-
【上海調劑】985聯(lián)合培養(yǎng)！別錯過能送你去交大/同濟/中科院的神仙導師！
已經(jīng)有4人回復
-
【#上海調劑急錄#】985聯(lián)合培養(yǎng)！別錯過能送你去交大/同濟/中科院的神仙導師！
已經(jīng)有9人回復
-
【#上海調劑急錄#】985聯(lián)合培養(yǎng)！代碼1007/1055/08..07...等速來！！
已經(jīng)有9人回復
-
SUES&NERCN課題組接受碩士生調劑 (學碩1名+專碩1名)
已經(jīng)有0人回復
» 本主題相關價值貼推薦，對您同樣有幫助:
- 鋰電池的兩篇review(Nature and Materials Research Bulletin)
已經(jīng)有286人回復
- Tier 2 Canada Research Chair in Organic and Medicinal Chemistry 是什么職稱？
已經(jīng)有3人回復
- PhD Position in Computer Vision from Queen Mary, University of London
已經(jīng)有16人回復
- Letters in Drug Design & Discovery這個期刊怎么投？
已經(jīng)有15人回復
- PhD research scholarship in Monash University, Australia
已經(jīng)有25人回復
- 幫我看看這個“約稿”是不是騙人的？Advances in Materials Research
已經(jīng)有9人回復
- 【Share】when i fall in love with you
已經(jīng)有58人回復
- 【招聘】PhD positions in Technical University of Darmstadt, Germany
已經(jīng)有3人回復
- Environmental Science and Pollution Research
已經(jīng)有14人回復
zlwcw
版主
- 應助: 1 (幼兒園)
- 金幣: 2021.1
- 散金: 225
- 紅花: 8
- 帖子: 1274
- 在線: 219.7小時
- 蟲號: 530429
- 注冊: 2008-03-21
- 性別: GG
- 專業(yè): 代謝性疾病藥物藥理
3樓2011-10-30 17:02:28
1994yw
實習版主
- 應助: 8 (幼兒園)
- 金幣: 1708.3
- 散金: 105
- 帖子: 646
- 在線: 79.5小時
- 蟲號: 1242523
- 注冊: 2011-03-23
- 專業(yè): 藥物設計與藥物信息
2樓2011-10-30 15:01:33
1994yw
兌換貴賓
- 應助: 8 (幼兒園)
- 金幣: 1708.3
- 散金: 105
- 帖子: 646
- 在線: 79.5小時
- 蟲號: 1242523
- 注冊: 2011-03-23
- 專業(yè): 藥物設計與藥物信息
★
小木蟲(金幣+0.5):給個紅包，謝謝回帖
小木蟲(金幣+0.5):給個紅包，謝謝回帖
|
搞錯了. i美股訊)北京時間10月24日晚消息，尚華醫(yī)藥今天表示，該公司通過旗下子公司——上海睿智化學研究有限公司公司已收購了CharlES River Laboratories International位于上海的體內藥物（In-vivo Drug ）研究室資產(chǎn)。Charles River 是全球領先的研究模式及相關服務和臨床前藥物研發(fā)服務提供商。 作為交易的一部分，尚華醫(yī)藥將接手Charles River對上海研究室的租賃。這起交易完成后，尚華醫(yī)藥將提供額外2，972平方米空間用于GLP Tox研究和1，290 平方米試驗和辦公空間。 注冊于開曼群島的尚華醫(yī)藥研發(fā)服務集團是上海睿智化學研究有限公司、上海凱惠醫(yī)藥化工有限公司及上海開拓者化學研究管理有限公司的控股公司。 上海睿智化學研究有限公司成立于2003年4月，公司坐落于中國藥谷——上海市浦東新區(qū)張江高科技園區(qū)生物醫(yī)藥基地內。公司目前主要從事為國內外客戶提供組合化學、藥物化學、合成化學等領域的科研服務；化工醫(yī)藥產(chǎn)品質量測試；醫(yī)藥生物技術引進、孵化以及成果產(chǎn)業(yè)化等業(yè)務。睿智化學擁有8500平方米左右的實驗室。實驗室中均采用世界一流的研究設備,除具有進行有機合成所必需的先進的實驗儀器設備外，還擁有核磁共振儀,液相色譜-質譜聯(lián)用儀,分析型高效液相色譜儀,制備型高效液相色譜儀等先進測試儀器。同時，睿智化學在上海設立了中試基地，具備精細化工產(chǎn)品的中試和加工能力。 上海開拓者化學研究管理有限公司成立于2002年6月，占地12000平方米,位于上海最重要的生物醫(yī)藥研發(fā)基地——張江高科技園區(qū)。 [ Last edited by 1994yw on 2011-10-31 at 21:08 ] |
4樓2011-10-31 21:05:03
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿085600中科院寧波所276分求調劑 +16 | 材料學257求調劑 2026-03-28 | 17/850 |
|
|---|---|---|---|---|
|
|
[考研] 070300化學專業(yè)279調劑 +10 | 哈哈哈^_^ 2026-03-31 | 10/500 |
|
|
[考研] 已決定調劑院校 +8 | JKSOIID 2026-03-26 | 8/400 |
|
|
|
[考研] 375求調劑 +7 | 雨夏整夜 2026-03-29 | 7/350 |
|
|
|
[考研] 070300一志愿211，312分求調劑院校 +12 | 小黃鴨寶 2026-03-30 | 12/600 |
|
|
|
[考研] 086000調劑 +5 | 7901117076 2026-03-26 | 5/250 |
|
|
|
[考研] 285求調劑 +6 | AZMK 2026-03-30 | 11/550 |
|
|
|
[考研] 340求調劑 +4 | 希望如此i 2026-03-31 | 4/200 |
|
|
|
[考研] 理學07化學 303求調劑 +8 | 睿08 2026-03-27 | 8/400 |
|
|
|
[考研]
 一志愿武漢理工，總分321，英一數(shù)二，求老師收留。
+12
|
nnnnnnn5 2026-03-25 | 12/600 |
|
|
|
[考研] 化學0703 調劑 306分 一志愿211 +10 | 26要上岸 2026-03-28 | 10/500 |
|
|
|
[基金申請] 面上5B能上會嗎？ +8 | redcom 2026-03-29 | 8/400 |
|
|
|
[考研] 353求調劑 +3 | 江上楓_26 2026-03-28 | 3/150 |
|
|
|
[考研] 一志愿中國科學院大學265求調劑 +6 | 恬淡ye 2026-03-31 | 7/350 |
|
|
|
[考研] 323分 食品與營養(yǎng)調劑 +3 | 嘿ooo 2026-03-31 | 3/150 |
|
|
|
[考研] 085701環(huán)境工程求調劑 +11 | 多久上課 2026-03-27 | 12/600 |
|
|
|
[考研] 071010 323 分求調劑 +3 | Baekzhy 2026-03-27 | 3/150 |
|
|
|
[考研] 284求調劑 +14 | junqihahaha 2026-03-26 | 15/750 |
|
|
|
[考研]
一志愿廈門大學化學學碩307求調劑
+10
|
y7czhao 2026-03-26 | 10/500 |
|
|
|
[考研] 【2026考研調劑】制藥工程 284分 求相關專業(yè)調劑名額 +4 | 袁奐奐 2026-03-25 | 8/400 |
|